[Leish-l] FW: Leishmaniasis Pathology Network

Fri Aug 12 22:40:11 BRT 2011

I would be very interested to be a collaborator in this network.Professor V.RameshDept. of Dermatology VM Medical CollegeNew Delhi

From: basupandey at wlink.com.np
To: jayusp at hotmail.com; leish-l at lineu.icb.usp.br
Date: Fri, 12 Aug 2011 20:24:36 +0545
Subject: Re: [Leish-l] FW: Leishmaniasis Pathology Network

I fully agree with the idea and this is to express our support Leishmania 
pathology network, we are
interested to participate and help pushing this 
idea forward. I will prepare 
support letter from our group will be send to 
you as soon as possible.

Dr. Basu Dev Pandey, MD, PhD
Everest International 
Clinic and Research Center 
Kathmandu, Nepal
Tel: 977-1-4253395
Email: 
basupandey at wlink.com.np

  ----- Original Message ----- 
  From: 
  jeffrey shaw 

  To: Leish-L 
  Sent: Tuesday, August 09, 2011 8:26 
  PM
  Subject: [Leish-l] FW: Leishmaniasis 
  Pathology Network

  Date: Tue, 9 Aug 2011 11:58:52 +0100
From: paul.kaye at york.ac.uk

Subject: 
  Leishmaniasis Pathology Network

  Dear all,
  Invitation to participate in a global pathology network 
  for research and training in leishmaniasis (LeishPathNet)
  You may recall the Dormy House meeting in 2008 and some 
  of the plans we put forward?  Over the past couple years, I 
  have also spoken more to a few of you about one idea that was formulated at 
  Dormy, namely of setting up a digital pathology network. I have also had 
  numerous discussions with the major equipment manufacturers to see if any of 
  them would be supportive of helping us to develop such an 
  initiative.  There have been two major develoments 
  recently.  First, Carl Zeiss is willing to work with us to 
  set up an integrated global digital pathology network (providing a significant 
  financial and technical contribution) and second, the Wellcome Trust is 
  willing to review a pre-proposal to fund the initiative through their new 
  Biomedical Resources Grant scheme (http://www.wellcome.ac.uk/Funding/Biomedical-science/Funding-schemes/Strategic-awards-and-initiatives/wtdv031727.htm) 
  .
  I have attached an outline of the project that I had 
  sent to the Trust for their initial views, which I think is reasonably 
  self-explanatory.  They appeared very 
  enthusiastic!  The main question now is whether enough of 
  you are still supportive? [ I will also be sending this email to others, but 
  please feel free to circulate ]

  I think the project will be challenging, but 
  success could have a real impact on the way we conduct business.  It 
  should serve not only as a vehicle to enhance research in leishmaniasis, but 
  the model would be equally applicable across a broad range of diseases and 
  global challenges (with leishmaniasis setting the pace).
  If we wish to proceed, the requirements are that 
  we submit a pre-proposal to the Trust by Oct 18th 
  2011.  This pre-proposal is short (4 sections of 350 
  words) and requires letters of support from the community.  

  If you are supportive of the idea that we try to 
  take this forward (and there is plenty of scope for later iteration of the 
  detail), I would be grateful if you could please provide me with a letter of 
  support by September 12th 2011, indicating whether you would 
  like to be a network partner if the bid is successful.  You 
  could also be supportive but not wish to become directly involved at this 
  stage, and such letters are equally valuable. Your letter might also stress 
  the added value that the network could provide, its importance for research 
  and training and/or for progressing the translational agenda.  
  It would also be an opportunity to indicate whether your group (or 
  institute, if multiple groups) would be interested in bidding to be one of the 
  initial ‘designated laboratories’.  
  If there is sufficient support to proceed and if 
  subsequently the pre-proposal is successful (we will know on 22nd 
  Nov), then I will need a few volunteers to help finalise the full proposal, 
  which will be due on Jan 26th 2012.  A funding 
  decision will be made on May 26th 2012. 
  Best wishes and of course I am happy to discuss 
  any points further (though I will be out of the UK from Aug 10 –Sept 
  12)
  Paul

-- 
Professor Paul Kaye, Ph.D., FRCPath.
Deputy Dean (Research), Hull York Medical School, and 
Director, Centre for Immunology and Infection
Department of Biology and Hull York Medical School
University of York
Wentworth Way
York YO10 5YW
United Kingdom

Tel:  +44 (0)1904 328840
Fax:  +44 (0)1904 328844
Email: paul.kaye at york.ac.uk <mailto:paul.kaye at york.ac.uk>

Centre Administrator and PA: Elizabeth Greensted
Tel:  01904 328845
Email: liz.greensted at york.ac.uk <mailto:liz.greensted at york.ac.uk>

Centre Email: cii at york.ac.uk <mailto:cii at york.ac.uk>

Centre website: http://www.york.ac.uk/cii

Times Higher Education University of the Year 2010

Email disclaimer: http://www.york.ac.uk/docs/disclaimer/email.htm

  _______________________________________________
Leish-l mailing 
  list
Leish-l at lineu.icb.usp.br
http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l

_______________________________________________
Leish-l mailing list
Leish-l at lineu.icb.usp.br
http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l 		 	   		  
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lineu.icb.usp.br/pipermail/leish-l/attachments/20110813/bdbc422e/attachment.htm>